ZA200910116B - Pharmaceutical composition comprising amlodipine and losartan - Google Patents

Pharmaceutical composition comprising amlodipine and losartan

Info

Publication number
ZA200910116B
ZA200910116B ZA200910116A ZA200910116A ZA200910116B ZA 200910116 B ZA200910116 B ZA 200910116B ZA 200910116 A ZA200910116 A ZA 200910116A ZA 200910116 A ZA200910116 A ZA 200910116A ZA 200910116 B ZA200910116 B ZA 200910116B
Authority
ZA
South Africa
Prior art keywords
losartan
amlodipine
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA200910116A
Other languages
English (en)
Inventor
Jong Soo Woo
Hong Gi Yi
Moon Hyuk Chi
Kyeong Soo Kim
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39492408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200910116(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of ZA200910116B publication Critical patent/ZA200910116B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200910116A 2006-12-08 2007-12-07 Pharmaceutical composition comprising amlodipine and losartan ZA200910116B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060124552A KR101247583B1 (ko) 2006-12-08 2006-12-08 암로디핀 또는 이의 약제학적 허용가능한 염, 및 로자탄또는 이의 약제학적 허용가능한 염을 함유하는 약제학적조성물

Publications (1)

Publication Number Publication Date
ZA200910116B true ZA200910116B (en) 2010-07-28

Family

ID=39492408

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200910116A ZA200910116B (en) 2006-12-08 2007-12-07 Pharmaceutical composition comprising amlodipine and losartan
ZA2008/10116A ZA200810116B (en) 2006-12-08 2008-11-27 Pharmaceutical composition comprising amlodipine and losartan

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA2008/10116A ZA200810116B (en) 2006-12-08 2008-11-27 Pharmaceutical composition comprising amlodipine and losartan

Country Status (20)

Country Link
US (1) US20100233261A1 (fr)
EP (1) EP2037917B1 (fr)
JP (1) JP4995912B2 (fr)
KR (1) KR101247583B1 (fr)
CN (1) CN101472587B (fr)
AU (1) AU2007328630B2 (fr)
BR (1) BRPI0713306A8 (fr)
CA (1) CA2654054C (fr)
EC (1) ECSP088980A (fr)
ES (1) ES2522567T3 (fr)
HK (1) HK1131916A1 (fr)
IL (1) IL195581A (fr)
MX (1) MX2008016099A (fr)
MY (1) MY144857A (fr)
NO (1) NO20085302L (fr)
NZ (1) NZ573223A (fr)
RU (1) RU2401107C2 (fr)
UA (1) UA92641C2 (fr)
WO (1) WO2008069612A1 (fr)
ZA (2) ZA200910116B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI503119B (zh) * 2009-01-23 2015-10-11 Hanmi Science Co Ltd 含有氨氯地平（ａｍｌｏｄｉｐｉｎｅ）及洛沙坦（ｌｏｓａｒｔａｎ）之固體藥學組成物及其製造方法
CN102292085B (zh) * 2009-01-23 2017-01-18 韩美科学株式会社 包含氨氯地平和氯沙坦的固体药物组合物及其制备方法
CN101849941B (zh) * 2009-04-02 2012-04-18 鲁南制药集团股份有限公司 一种治疗高血压的药物组合物
CN101849942B (zh) * 2009-04-02 2012-05-23 鲁南制药集团股份有限公司 治疗高血压的药物组合物
US9173848B2 (en) * 2009-06-30 2015-11-03 Sanofi Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
JP2011136908A (ja) * 2009-12-25 2011-07-14 Kyowa Yakuhin Kogyo Kk アンギオテンシンｉｉ受容体拮抗剤を含む固形製剤および固形製剤におけるアンギオテンシンｉｉ受容体拮抗剤の保存安定性向上方法
WO2012055941A1 (fr) * 2010-10-27 2012-05-03 Krka,Tovarna Zdravil, D. D., Novo Mesto Composition pharmaceutique multicouche comprenant du telmisartan et de l'amlodipine
CN102335172B (zh) * 2011-07-20 2012-12-12 海南锦瑞制药股份有限公司 一种氨氯地平与氯沙坦钾药用组合物及其制备方法
KR101907881B1 (ko) * 2011-12-30 2018-12-11 한미약품 주식회사 로자탄, 암로디핀 및 히드로클로로티아자이드를 포함하는 고정 용량 조합 제형
KR101392364B1 (ko) * 2012-04-17 2014-05-07 한국유나이티드제약 주식회사 안정성이 향상된 암로디핀 및 로잘탄을 함유하는 복합제 조성물
KR101910901B1 (ko) * 2013-11-29 2018-10-24 한미약품 주식회사 암로디핀, 로자탄 및 로수바스타틴을 포함하는 약제학적 복합 제제
KR20150078215A (ko) * 2013-12-30 2015-07-08 (주) 드림파마 에프로사탄 및 암로디핀을 포함하는 복합제제 및 이의 제조방법
KR102369607B1 (ko) * 2014-09-30 2022-03-03 한미약품 주식회사 암로디핀 및 로잘탄을 포함하는 고형 약제학적 조성물
KR101914930B1 (ko) * 2015-03-31 2018-11-05 한미약품 주식회사 암로디핀, 로자탄 및 클로르탈리돈을 포함하는 약제학적 복합 제제
KR101750689B1 (ko) * 2015-09-15 2017-06-26 주식회사 종근당 약제학적 복합제제
KR101710441B1 (ko) * 2015-12-28 2017-02-28 신풍제약주식회사 안정성 및 용출성이 향상된 정제
CN110215455A (zh) * 2019-03-26 2019-09-10 山东省药学科学院 一种用于降血压的药物配方
CN112274490B (zh) * 2020-11-19 2022-11-22 四川尚锐生物医药有限公司 一种氨氯地平氯沙坦钾复方组合物的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2257946A1 (fr) * 1996-06-24 1997-12-31 Merck & Co., Inc. Composition a base d'enalapril et de losartan
WO2000027397A1 (fr) * 1998-11-06 2000-05-18 Glaxo Group Limited Medicaments antihypertenseurs a base de lacidipine et de telmisartan
EP1314425A4 (fr) 2000-08-30 2004-06-02 Sankyo Co Compositions medicinales utilisees dans la prevention ou le traitement de l'insuffisance cardiaque
US20040137062A1 (en) * 2001-05-25 2004-07-15 Sham Chopra Chronotherapy tablet and methods related thereto
EP1587792B1 (fr) * 2003-01-27 2014-08-27 Hanmi Science Co., Ltd. Amlodipine camsylate stable et amorphe, procede de preparation associe et composition pour l'administration orale
AU2004208615C1 (en) * 2003-01-31 2010-05-13 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
AR043395A1 (es) * 2003-02-28 2005-07-27 Recordati Ireland Ltd Terapia de combinacion para la hipertension utilizando lercanidipina y un bloqueante de los receptores de angiotensina ii
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US20050187262A1 (en) * 2004-01-12 2005-08-25 Grogan Donna R. Compositions comprising (S)-amlodipine and an angiotensin receptor blocker and methods of their use
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
CA2582049C (fr) * 2004-11-05 2010-08-24 Boehringer Ingelheim International Gmbh Comprime bicouche contenant du telmisartan et de l'amlodipine
TWI388345B (zh) * 2005-06-27 2013-03-11 Sankyo Co 用於高血壓之預防或治療之包含血管緊張素ⅱ受體拮抗劑及鈣通道阻斷劑之固體劑型
KR100888131B1 (ko) * 2006-10-10 2009-03-11 한올제약주식회사 시간차 투약 원리를 이용한 심혈관계 질환 치료용 복합제제

Also Published As

Publication number Publication date
RU2401107C2 (ru) 2010-10-10
AU2007328630A1 (en) 2008-06-12
EP2037917A4 (fr) 2010-08-04
US20100233261A1 (en) 2010-09-16
NZ573223A (en) 2012-07-27
KR101247583B1 (ko) 2013-03-26
EP2037917B1 (fr) 2014-10-08
CA2654054C (fr) 2013-01-08
NO20085302L (no) 2009-06-17
ES2522567T3 (es) 2014-11-17
JP2009544752A (ja) 2009-12-17
UA92641C2 (ru) 2010-11-25
ZA200810116B (en) 2010-07-28
ECSP088980A (es) 2009-02-27
IL195581A0 (en) 2009-09-01
WO2008069612A1 (fr) 2008-06-12
RU2008150477A (ru) 2010-06-27
IL195581A (en) 2015-08-31
JP4995912B2 (ja) 2012-08-08
CN101472587A (zh) 2009-07-01
EP2037917A1 (fr) 2009-03-25
BRPI0713306A2 (pt) 2012-04-17
HK1131916A1 (en) 2010-02-12
KR20080052852A (ko) 2008-06-12
MX2008016099A (es) 2009-01-19
CA2654054A1 (fr) 2008-06-12
CN101472587B (zh) 2013-11-20
AU2007328630B2 (en) 2010-03-11
MY144857A (en) 2011-11-30
BRPI0713306A8 (pt) 2016-06-07

Similar Documents

Publication Publication Date Title
ZA200810116B (en) Pharmaceutical composition comprising amlodipine and losartan
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
EP2056835A4 (fr) Compositions pharmaceutiques et leurs utilisations
HK1163539A1 (en) Solid pharmaceutical composition comprising amlodipine and losartan
IL192613A (en) Cycloalkylamines and their pharmaceutical compositions
EP2025337A4 (fr) Composition pharmaceutique externe
EP2005959A4 (fr) Composition pharmaceutique externe
PL2005958T3 (pl) Kompozycja farmaceutyczna do stosowania zewnętrznego
IL194751A0 (en) Drugs and uses
GB0621160D0 (en) Compounds and uses thereof
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
GB0610090D0 (en) Particulate drug compositions and their uses
EP2070919A4 (fr) Composé de spiroquinone et composition pharmaceutique
EP2124908A4 (fr) Composés et utilisations de ceux-ci
HK1130049A1 (en) Tricyclic compound and pharmaceutical use thereof
EP2098513A4 (fr) Composé tricyclique et son utilisation pharmaceutique
GB0614365D0 (en) Pharmaceutical compositions and their use
EP2124959A4 (fr) Composition pharmaceutique
EP2120563A4 (fr) Composés et leurs utilisations
EP2114404A4 (fr) Composé et composition pharmaceutiques
GB0600336D0 (en) Composition and uses thereof
EP2099459A4 (fr) Composés et leurs utilisations
GB0701295D0 (en) Z-stilbenes derivatives and the pharmaceutical composition thereof
EP2120957A4 (fr) Composés et leurs utilisations
TWI349668B (en) Selenophene compounds and pharmaceutical composition